Delivery Order SPE2DB24D9238-SPE2DB25FDQTC

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,905.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
This federal contract award, valued at $4,724.16, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order to supply the Defense Department with ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,642.71 contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,115.64 firm-fixed-price contract is for the supply of the pharmaceutical product "ENGERIX-B 20 MCG/ML SYRNML" with a completion date of June 18, 2024. The award is under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,603.16 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award, valued at $1,968.40, was issued by the Defense agency's Medical Supply Chain to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Engerix-B 20 MCG/ML SYRN, a pharmaceutical product, with a completion date of April 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued at up to $4,999,999, with the Defense Logistics Agency under the SPE2DB program. This...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of ENGERIX-B 20 MCG/ML SYRN pharmaceutical items to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $1,865.55, was awarded on May 16, 2022 and is set to be completed by May 17, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $5,596.65 firm fixed price delivery order is for the pharmaceutical product ENGERIX-B 20 MCG/ML SYRN. DMS Pharmaceutical Group holds various contracts and indefinite delivery vehicles (IDVs) with DLA to provide pharmaceuticals and medical supplies to support military treatment facilities worldwide. This delivery order is...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,818.72, is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has an ultimate completion date of March 12, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $3,731.10 award is for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense, through...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB25FDQTC
    Delivery Order

This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The $10,912.32 firm fixed-price delivery order is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, and DMS Pharmaceutical Group has secured this award leveraging its status as a woman-owned small business. The company is a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 7/22/25, 9:43 AM